Mizzen L
StressGen Biotechnologies Corporation, Victoria, British Columbia, Canada.
Biotherapy. 1998;10(3):173-89. doi: 10.1007/BF02678295.
Heat shock proteins, or stress proteins have been identified as part of a highly conserved cellular defence mechanism mediated by multiple, distinct gene families and corresponding gene products. As intracellular chaperones, stress proteins participate in many essential biochemical pathways of protein maturation and function active during times of stress and during normal cellular homeostasis. In addition to their well-characterized role as protein chaperones, stress proteins are now realized to possess another important biological property: immunogenicity. Stress proteins are now understood to play a fundamental role in immune surveillance of infection and malignancy and this body of basic research has provided a framework for their clinical application. As key targets of both humoral and cellular immunity during infection, stress proteins have accordingly received considerable research interest as prophylactic vaccines for infectious disease applications. The unique and potent immunostimulatory properties of stress proteins have similarly been applied to the development of new approaches to cancer therapy, including both protein and gene-based modalities.
热休克蛋白或应激蛋白已被确定为一种高度保守的细胞防御机制的一部分,该机制由多个不同的基因家族和相应的基因产物介导。作为细胞内伴侣蛋白,应激蛋白参与蛋白质成熟的许多重要生化途径,并在应激期间和正常细胞稳态期间发挥功能活性。除了作为蛋白伴侣的特征性作用外,应激蛋白现在还被认为具有另一个重要的生物学特性:免疫原性。应激蛋白现在被理解为在感染和恶性肿瘤的免疫监视中发挥基本作用,并且这一系列基础研究为它们的临床应用提供了框架。作为感染期间体液免疫和细胞免疫的关键靶点,应激蛋白因此作为传染病应用的预防性疫苗受到了相当多的研究关注。应激蛋白独特而强大的免疫刺激特性同样被应用于癌症治疗新方法的开发,包括基于蛋白质和基因的方式。